APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABAB Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global GABAB Receptor Agonists Industry Growth and Trends Forecast to 2032

20 December 2025103 pages

Choose your research edition.

Industry ResearchGABAB Receptor Agonists Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal GABAB Receptor Agonists Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal GABAB Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABAB Receptor Agonists Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal GABAB Receptor Agonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global GABAB Receptor Agonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for GABAB Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for GABAB Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABAB Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GABAB Receptor Agonists include Xi'an Libang Pharmaceuticals, Xi'an Hanfeng Pharmaceuticals, Sun Pharma, Hemony Pharmaceutical, Sichuan Ren'an Pharmaceuticals, Novartis, Nanjing Haina Pharmaceutical, China Resources Double Crane Pharmaceuticals and Fuan Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global GABAB Receptor Agonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The GABAB Receptor Agonists market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GABAB Receptor Agonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GABAB Receptor Agonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global GABAB Receptor Agonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

GABAB Receptor Agonists Market by Company

Xi'an Libang Pharmaceuticals

Xi'an Hanfeng Pharmaceuticals

Sun Pharma

Hemony Pharmaceutical

Sichuan Ren'an Pharmaceuticals

Novartis

Nanjing Haina Pharmaceutical

China Resources Double Crane Pharmaceuticals

Fuan Pharmaceutical Group

Chengdu Beite

Viatris

Jazz Pharmaceuicals

Hikma

GABAB Receptor Agonists Segment by Type

Baclofen

γ-hydroxybutyrate(GHB)）

GABAB Receptor Agonists Segment by Application

Hospital

Clinic

Other

GABAB Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABAB Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABAB Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABAB Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GABAB Receptor Agonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of GABAB Receptor Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Baclofen Table 2. Major Company of γ-hydroxybutyrate(GHB)） Table 3. Global GABAB Receptor Agonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 5. Global GABAB Receptor Agonists Sales Market Share in Volume by Type (2021-2026) Table 6. Global GABAB Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 7. Global GABAB Receptor Agonists Sales Market Share in Value by Type (2021-2026) Table 8. Global GABAB Receptor Agonists Price by Type (2021-2026) & (US$/Unit) Table 9. Global GABAB Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 10. Global GABAB Receptor Agonists Sales Market Share in Volume by Type (2027-2032) Table 11. Global GABAB Receptor Agonists Sales by Type (2027-2032) & (US$ Million) Table 12. Global GABAB Receptor Agonists Sales Market Share in Value by Type (2027-2032) Table 13. Global GABAB Receptor Agonists Price by Type (2027-2032) & (US$/Unit) Table 14. North America GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 15. North America GABAB Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 16. Europe GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 17. Europe GABAB Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific GABAB Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 21. Latin America GABAB Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa GABAB Receptor Agonists Sales by Type (2021-2026) & (US$ Million) Table 24. GABAB Receptor Agonists Industry Trends Table 25. GABAB Receptor Agonists Industry Drivers Table 26. GABAB Receptor Agonists Industry Opportunities and Challenges Table 27. GABAB Receptor Agonists Industry Restraints Table 28. Global GABAB Receptor Agonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global GABAB Receptor Agonists Revenue Market Share by Company (2021-2026) Table 30. Global GABAB Receptor Agonists Sales by Company (2021-2026) & (K Units) Table 31. Global GABAB Receptor Agonists Sales Share by Company (2021-2026) Table 32. Global GABAB Receptor Agonists Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global GABAB Receptor Agonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global GABAB Receptor Agonists Major Company Production Sites and Headquarters Table 35. Global GABAB Receptor Agonists Company, Product Type & Application Table 36. Global GABAB Receptor Agonists Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global GABAB Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global GABAB Receptor Agonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global GABAB Receptor Agonists Sales by Region (2021-2026) & (K Units) Table 41. Global GABAB Receptor Agonists Sales Market Share in Volume by Region (2021-2026) Table 42. Global GABAB Receptor Agonists Sales by Region (2021-2026) & (US$ Million) Table 43. Global GABAB Receptor Agonists Sales Market Share in Value by Region (2021-2026) Table 44. Global GABAB Receptor Agonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global GABAB Receptor Agonists Sales by Region (2027-2032) & (K Units) Table 46. Global GABAB Receptor Agonists Sales Market Share in Volume by Region (2027-2032) Table 47. Global GABAB Receptor Agonists Sales by Region (2027-2032) & (US$ Million) Table 48. Global GABAB Receptor Agonists Sales Market Share in Value by Region (2027-2032) Table 49. Global GABAB Receptor Agonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global GABAB Receptor Agonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 52. Global GABAB Receptor Agonists Sales Market Share in Volume by Application (2021-2026) Table 53. Global GABAB Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 54. Global GABAB Receptor Agonists Sales Market Share in Value by Application (2021-2026) Table 55. Global GABAB Receptor Agonists Price by Application (2021-2026) & (US$/Unit) Table 56. Global GABAB Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 57. Global GABAB Receptor Agonists Sales Market Share in Volume by Application (2027-2032) Table 58. Global GABAB Receptor Agonists Sales by Application (2027-2032) & (US$ Million) Table 59. Global GABAB Receptor Agonists Sales Market Share in Value by Application (2027-2032) Table 60. Global GABAB Receptor Agonists Price by Application (2027-2032) & (US$/Unit) Table 61. North America GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 62. North America GABAB Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 63. Europe GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 64. Europe GABAB Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific GABAB Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 68. Latin America GABAB Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa GABAB Receptor Agonists Sales by Application (2021-2026) & (US$ Million) Table 71. Xi'an Libang Pharmaceuticals Company Information Table 72. Xi'an Libang Pharmaceuticals Business Overview Table 73. Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 75. Xi'an Libang Pharmaceuticals Recent Development Table 76. Xi'an Hanfeng Pharmaceuticals Company Information Table 77. Xi'an Hanfeng Pharmaceuticals Business Overview Table 78. Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 80. Xi'an Hanfeng Pharmaceuticals Recent Development Table 81. Sun Pharma Company Information Table 82. Sun Pharma Business Overview Table 83. Sun Pharma GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sun Pharma GABAB Receptor Agonists Product Portfolio Table 85. Sun Pharma Recent Development Table 86. Hemony Pharmaceutical Company Information Table 87. Hemony Pharmaceutical Business Overview Table 88. Hemony Pharmaceutical GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hemony Pharmaceutical GABAB Receptor Agonists Product Portfolio Table 90. Hemony Pharmaceutical Recent Development Table 91. Sichuan Ren'an Pharmaceuticals Company Information Table 92. Sichuan Ren'an Pharmaceuticals Business Overview Table 93. Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 95. Sichuan Ren'an Pharmaceuticals Recent Development Table 96. Novartis Company Information Table 97. Novartis Business Overview Table 98. Novartis GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Novartis GABAB Receptor Agonists Product Portfolio Table 100. Novartis Recent Development Table 101. Nanjing Haina Pharmaceutical Company Information Table 102. Nanjing Haina Pharmaceutical Business Overview Table 103. Nanjing Haina Pharmaceutical GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Nanjing Haina Pharmaceutical GABAB Receptor Agonists Product Portfolio Table 105. Nanjing Haina Pharmaceutical Recent Development Table 106. China Resources Double Crane Pharmaceuticals Company Information Table 107. China Resources Double Crane Pharmaceuticals Business Overview Table 108. China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 110. China Resources Double Crane Pharmaceuticals Recent Development Table 111. Fuan Pharmaceutical Group Company Information Table 112. Fuan Pharmaceutical Group Business Overview Table 113. Fuan Pharmaceutical Group GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Fuan Pharmaceutical Group GABAB Receptor Agonists Product Portfolio Table 115. Fuan Pharmaceutical Group Recent Development Table 116. Chengdu Beite Company Information Table 117. Chengdu Beite Business Overview Table 118. Chengdu Beite GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Chengdu Beite GABAB Receptor Agonists Product Portfolio Table 120. Chengdu Beite Recent Development Table 121. Viatris Company Information Table 122. Viatris Business Overview Table 123. Viatris GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Viatris GABAB Receptor Agonists Product Portfolio Table 125. Viatris Recent Development Table 126. Jazz Pharmaceuicals Company Information Table 127. Jazz Pharmaceuicals Business Overview Table 128. Jazz Pharmaceuicals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jazz Pharmaceuicals GABAB Receptor Agonists Product Portfolio Table 130. Jazz Pharmaceuicals Recent Development Table 131. Hikma Company Information Table 132. Hikma Business Overview Table 133. Hikma GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Hikma GABAB Receptor Agonists Product Portfolio Table 135. Hikma Recent Development Table 136. North America GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 138. North America GABAB Receptor Agonists Sales Market Share by Country (2021-2026) Table 139. North America GABAB Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America GABAB Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 141. North America GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America GABAB Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 143. North America GABAB Receptor Agonists Market Share by Country (2021-2026) Table 144. North America GABAB Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America GABAB Receptor Agonists Market Share Forecast by Country (2027-2032) Table 146. Europe GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 148. Europe GABAB Receptor Agonists Sales Market Share by Country (2021-2026) Table 149. Europe GABAB Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe GABAB Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 151. Europe GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe GABAB Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe GABAB Receptor Agonists Market Share by Country (2021-2026) Table 154. Europe GABAB Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe GABAB Receptor Agonists Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific GABAB Receptor Agonists Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific GABAB Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific GABAB Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific GABAB Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific GABAB Receptor Agonists Market Share by Country (2021-2026) Table 164. Asia-Pacific GABAB Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific GABAB Receptor Agonists Market Share Forecast by Country (2027-2032) Table 166. Latin America GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 168. Latin America GABAB Receptor Agonists Sales Market Share by Country (2021-2026) Table 169. Latin America GABAB Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America GABAB Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America GABAB Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America GABAB Receptor Agonists Market Share by Country (2021-2026) Table 174. Latin America GABAB Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America GABAB Receptor Agonists Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa GABAB Receptor Agonists Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa GABAB Receptor Agonists Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa GABAB Receptor Agonists Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa GABAB Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa GABAB Receptor Agonists Market Share by Country (2021-2026) Table 184. Middle East and Africa GABAB Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa GABAB Receptor Agonists Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. GABAB Receptor Agonists Distributors List Table 189. GABAB Receptor Agonists Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. GABAB Receptor Agonists Image Figure 2. Global GABAB Receptor Agonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABAB Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 4. Global GABAB Receptor Agonists Sales (2021-2032) & (K Units) Figure 5. Baclofen Image Figure 6. Global Baclofen Sales YoY Growth (2021-2032) & (K Units) Figure 7. γ-hydroxybutyrate(GHB)） Image Figure 8. Global γ-hydroxybutyrate(GHB)） Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global GABAB Receptor Agonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global GABAB Receptor Agonists Market Share by Type 2025 VS 2032 Figure 11. North America GABAB Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 12. North America GABAB Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 13. Europe GABAB Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 14. Europe GABAB Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific GABAB Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific GABAB Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 17. Latin America GABAB Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 18. Latin America GABAB Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa GABAB Receptor Agonists Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa GABAB Receptor Agonists Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 GABAB Receptor Agonists Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global GABAB Receptor Agonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global GABAB Receptor Agonists Market Share by Application 2025 VS 2032 Figure 31. North America GABAB Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 32. North America GABAB Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 33. Europe GABAB Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 34. Europe GABAB Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific GABAB Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific GABAB Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 37. Latin America GABAB Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 38. Latin America GABAB Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa GABAB Receptor Agonists Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa GABAB Receptor Agonists Sales Market Share in Value by Application in 2025 Figure 41. North America GABAB Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America GABAB Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America GABAB Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America GABAB Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe GABAB Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe GABAB Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe GABAB Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe GABAB Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific GABAB Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific GABAB Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific GABAB Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific GABAB Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America GABAB Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America GABAB Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America GABAB Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America GABAB Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa GABAB Receptor Agonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa GABAB Receptor Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa GABAB Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa GABAB Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. GABAB Receptor Agonists Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. GABAB Receptor Agonists Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Baclofen
  • γ-hydroxybutyrate(GHB)）
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Xi'an Libang Pharmaceuticals
  • Xi'an Hanfeng Pharmaceuticals
  • Sun Pharma
  • Hemony Pharmaceutical
  • Sichuan Ren'an Pharmaceuticals
  • Novartis
  • Nanjing Haina Pharmaceutical
  • China Resources Double Crane Pharmaceuticals
  • Fuan Pharmaceutical Group
  • Chengdu Beite
  • Viatris
  • Jazz Pharmaceuicals
  • Hikma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GABAB Receptor Agonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GABAB Receptor Agonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 GABAB Receptor Agonists Market by Type
  6. 1.3.1 Baclofen
  7. 1.3.2 γ-hydroxybutyrate(GHB)）
  8. 1.4 Global GABAB Receptor Agonists Market Size by Type
  9. 1.4.1 Global GABAB Receptor Agonists Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global GABAB Receptor Agonists Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global GABAB Receptor Agonists Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America GABAB Receptor Agonists Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe GABAB Receptor Agonists Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific GABAB Receptor Agonists Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America GABAB Receptor Agonists Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa GABAB Receptor Agonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 GABAB Receptor Agonists Industry Trends
  2. 2.2 GABAB Receptor Agonists Industry Drivers
  3. 2.3 GABAB Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 GABAB Receptor Agonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by GABAB Receptor Agonists Revenue (2021-2026)
  2. 3.2 Global Top Players by GABAB Receptor Agonists Sales (2021-2026)
  3. 3.3 Global Top Players by GABAB Receptor Agonists Price (2021-2026)
  4. 3.4 Global GABAB Receptor Agonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GABAB Receptor Agonists Major Company Production Sites & Headquarters
  6. 3.6 Global GABAB Receptor Agonists Company, Product Type & Application
  7. 3.7 Global GABAB Receptor Agonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GABAB Receptor Agonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GABAB Receptor Agonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GABAB Receptor Agonists Tier 1, Tier 2, and Tier 3
4 GABAB Receptor Agonists Regional Status and Outlook
  1. 4.1 Global GABAB Receptor Agonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global GABAB Receptor Agonists Historic Market Size by Region
  3. 4.2.1 Global GABAB Receptor Agonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global GABAB Receptor Agonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global GABAB Receptor Agonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global GABAB Receptor Agonists Forecasted Market Size by Region
  7. 4.3.1 Global GABAB Receptor Agonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global GABAB Receptor Agonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global GABAB Receptor Agonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GABAB Receptor Agonists by Application
  1. 5.1 GABAB Receptor Agonists Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global GABAB Receptor Agonists Market Size by Application
  6. 5.2.1 Global GABAB Receptor Agonists Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global GABAB Receptor Agonists Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global GABAB Receptor Agonists Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America GABAB Receptor Agonists Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe GABAB Receptor Agonists Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific GABAB Receptor Agonists Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America GABAB Receptor Agonists Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa GABAB Receptor Agonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Xi'an Libang Pharmaceuticals
  2. 6.1.1 Xi'an Libang Pharmaceuticals Company Information
  3. 6.1.2 Xi'an Libang Pharmaceuticals Business Overview
  4. 6.1.3 Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  6. 6.1.5 Xi'an Libang Pharmaceuticals Recent Developments
  7. 6.2 Xi'an Hanfeng Pharmaceuticals
  8. 6.2.1 Xi'an Hanfeng Pharmaceuticals Company Information
  9. 6.2.2 Xi'an Hanfeng Pharmaceuticals Business Overview
  10. 6.2.3 Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  12. 6.2.5 Xi'an Hanfeng Pharmaceuticals Recent Developments
  13. 6.3 Sun Pharma
  14. 6.3.1 Sun Pharma Company Information
  15. 6.3.2 Sun Pharma Business Overview
  16. 6.3.3 Sun Pharma GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharma GABAB Receptor Agonists Product Portfolio
  18. 6.3.5 Sun Pharma Recent Developments
  19. 6.4 Hemony Pharmaceutical
  20. 6.4.1 Hemony Pharmaceutical Company Information
  21. 6.4.2 Hemony Pharmaceutical Business Overview
  22. 6.4.3 Hemony Pharmaceutical GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hemony Pharmaceutical GABAB Receptor Agonists Product Portfolio
  24. 6.4.5 Hemony Pharmaceutical Recent Developments
  25. 6.5 Sichuan Ren'an Pharmaceuticals
  26. 6.5.1 Sichuan Ren'an Pharmaceuticals Company Information
  27. 6.5.2 Sichuan Ren'an Pharmaceuticals Business Overview
  28. 6.5.3 Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  30. 6.5.5 Sichuan Ren'an Pharmaceuticals Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis GABAB Receptor Agonists Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Nanjing Haina Pharmaceutical
  38. 6.7.1 Nanjing Haina Pharmaceutical Company Information
  39. 6.7.2 Nanjing Haina Pharmaceutical Business Overview
  40. 6.7.3 Nanjing Haina Pharmaceutical GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nanjing Haina Pharmaceutical GABAB Receptor Agonists Product Portfolio
  42. 6.7.5 Nanjing Haina Pharmaceutical Recent Developments
  43. 6.8 China Resources Double Crane Pharmaceuticals
  44. 6.8.1 China Resources Double Crane Pharmaceuticals Company Information
  45. 6.8.2 China Resources Double Crane Pharmaceuticals Business Overview
  46. 6.8.3 China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  48. 6.8.5 China Resources Double Crane Pharmaceuticals Recent Developments
  49. 6.9 Fuan Pharmaceutical Group
  50. 6.9.1 Fuan Pharmaceutical Group Company Information
  51. 6.9.2 Fuan Pharmaceutical Group Business Overview
  52. 6.9.3 Fuan Pharmaceutical Group GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Fuan Pharmaceutical Group GABAB Receptor Agonists Product Portfolio
  54. 6.9.5 Fuan Pharmaceutical Group Recent Developments
  55. 6.10 Chengdu Beite
  56. 6.10.1 Chengdu Beite Company Information
  57. 6.10.2 Chengdu Beite Business Overview
  58. 6.10.3 Chengdu Beite GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu Beite GABAB Receptor Agonists Product Portfolio
  60. 6.10.5 Chengdu Beite Recent Developments
  61. 6.11 Viatris
  62. 6.11.1 Viatris Company Information
  63. 6.11.2 Viatris Business Overview
  64. 6.11.3 Viatris GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Viatris GABAB Receptor Agonists Product Portfolio
  66. 6.11.5 Viatris Recent Developments
  67. 6.12 Jazz Pharmaceuicals
  68. 6.12.1 Jazz Pharmaceuicals Company Information
  69. 6.12.2 Jazz Pharmaceuicals Business Overview
  70. 6.12.3 Jazz Pharmaceuicals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jazz Pharmaceuicals GABAB Receptor Agonists Product Portfolio
  72. 6.12.5 Jazz Pharmaceuicals Recent Developments
  73. 6.13 Hikma
  74. 6.13.1 Hikma Company Information
  75. 6.13.2 Hikma Business Overview
  76. 6.13.3 Hikma GABAB Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hikma GABAB Receptor Agonists Product Portfolio
  78. 6.13.5 Hikma Recent Developments
7 North America by Country
  1. 7.1 North America GABAB Receptor Agonists Sales by Country
  2. 7.1.1 North America GABAB Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America GABAB Receptor Agonists Sales by Country (2021-2026)
  4. 7.1.3 North America GABAB Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America GABAB Receptor Agonists Market Size by Country
  6. 7.2.1 North America GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America GABAB Receptor Agonists Market Size by Country (2021-2026)
  8. 7.2.3 North America GABAB Receptor Agonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe GABAB Receptor Agonists Sales by Country
  2. 8.1.1 Europe GABAB Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe GABAB Receptor Agonists Sales by Country (2021-2026)
  4. 8.1.3 Europe GABAB Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe GABAB Receptor Agonists Market Size by Country
  6. 8.2.1 Europe GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe GABAB Receptor Agonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe GABAB Receptor Agonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific GABAB Receptor Agonists Sales by Country
  2. 9.1.1 Asia-Pacific GABAB Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific GABAB Receptor Agonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific GABAB Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific GABAB Receptor Agonists Market Size by Country
  6. 9.2.1 Asia-Pacific GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific GABAB Receptor Agonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific GABAB Receptor Agonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America GABAB Receptor Agonists Sales by Country
  2. 10.1.1 South America GABAB Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America GABAB Receptor Agonists Sales by Country (2021-2026)
  4. 10.1.3 South America GABAB Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America GABAB Receptor Agonists Market Size by Country
  6. 10.2.1 South America GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America GABAB Receptor Agonists Market Size by Country (2021-2026)
  8. 10.2.3 South America GABAB Receptor Agonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa GABAB Receptor Agonists Sales by Country
  2. 11.1.1 Middle East and Africa GABAB Receptor Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa GABAB Receptor Agonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa GABAB Receptor Agonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa GABAB Receptor Agonists Market Size by Country
  6. 11.2.1 Middle East and Africa GABAB Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa GABAB Receptor Agonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa GABAB Receptor Agonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 GABAB Receptor Agonists Value Chain Analysis
  2. 12.1.1 GABAB Receptor Agonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 GABAB Receptor Agonists Production Mode & Process
  7. 12.2 GABAB Receptor Agonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 GABAB Receptor Agonists Distributors
  10. 12.2.3 GABAB Receptor Agonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst